Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Tecan Genomics, Inc.
*MAILING ADDRESS
900 Chesapeake Drive
*CITY
Redwood City
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94063
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
001
*IDENTIFICATION
Biochemical reagents for scientific or research purposes, in particular for use related to nucleic acid sequencing; Biochemical reagents for
scientific or research purposes, in particular for use in genomic research; Biochemical reagents for scientific or research purposes, in particular for making DNA and RNA libraries for genomic
sequencing; Biochemical reagents for scientific or research purposes, in particular for measuring molarity of libraries for sequencing; Biochemical reagents for clinical-diagnostic laboratory or
research use, in particular for use related to nucleic acid sequencing; Biochemical reagents for clinical-diagnostic laboratory or research use, in particular for use in laboratory or research
clinical nucleic acid-based diagnostics
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
005
*IDENTIFICATION
Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for use related to nucleic acid
sequencing; Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for use in clinical medical or veterinary nucleic acid-based diagnostics;
Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for making DNA and RNA libraries for genomic sequencing; Biochemical reagents for clinical
medical diagnostic use and use in veterinary medicine, in particular for measuring molarity of libraries for sequencing
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Peter J. Willsey
ATTORNEY DOCKET NUMBER
34079/553
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Brown Rudnick LLP
STREET
601 Thirteenth Street NW Suite 600
CITY
Washington
STATE
District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
20005
PHONE
202-536-1751
FAX
617-289-0851
EMAIL ADDRESS
trademarks@brownrudnick.com
OTHER APPOINTED ATTORNEY
Vincent J. Badolato, Jason M. Sobel, Ian G. DiBernardo, Robert J. Tosti and Alvin B. Carter III
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97178464
Filing Date:12/17/2021
To the Commissioner for Trademarks:
MARK: NUQUANT (Standard Characters, see mark)
The literal element of the mark consists of NUQUANT. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Tecan Genomics, Inc., a corporation of Delaware, having an address of
900 Chesapeake Drive
Redwood City, California 94063
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 001: Biochemical reagents for scientific or research purposes, in particular for use related to nucleic acid sequencing; Biochemical reagents for scientific or research
purposes, in particular for use in genomic research; Biochemical reagents for scientific or research purposes, in particular for making DNA and RNA libraries for genomic sequencing; Biochemical
reagents for scientific or research purposes, in particular for measuring molarity of libraries for sequencing; Biochemical reagents for clinical-diagnostic laboratory or research use, in particular
for use related to nucleic acid sequencing; Biochemical reagents for clinical-diagnostic laboratory or research use, in particular for use in laboratory or research clinical nucleic acid-based
diagnostics
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 005: Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for use related to nucleic acid sequencing; Biochemical reagents
for clinical medical diagnostic use and use in veterinary medicine, in particular for use in clinical medical or veterinary nucleic acid-based diagnostics; Biochemical reagents for clinical medical
diagnostic use and use in veterinary medicine, in particular for making DNA and RNA libraries for genomic sequencing; Biochemical reagents for clinical medical diagnostic use and use in veterinary
medicine, in particular for measuring molarity of libraries for sequencing
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Peter J. Willsey. Other appointed attorneys are Vincent J. Badolato, Jason M. Sobel, Ian G. DiBernardo, Robert J. Tosti and Alvin B. Carter
III. Peter J. Willsey of Brown Rudnick LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
601 Thirteenth Street NW Suite 600
Washington, District of Columbia 20005
United States
202-536-1751(phone)
617-289-0851(fax)
trademarks@brownrudnick.com
The docket/reference number is 34079/553.
Peter J. Willsey submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /Leonard J. Goren/ Date: 12/17/2021
Signatory's Name: Leonard J. Goren
Signatory's Position: General Manager
Signatory's Phone Number: 1-650-590-3660
Signature method: Sent to third party for signature
Payment Sale Number: 97178464
Payment Accounting Date: 12/17/2021
Serial Number: 97178464
Internet Transmission Date: Fri Dec 17 17:25:43 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.X.XX-202112171725430775
68-97178464-781cbf6a651ea8d4adff69c8ea39
5bbb2ed183b28b53258bf27ac1559b7e27a5-DA-
25421925-20211217152644980099